---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-217455"
form_type: "8-K"
ticker: "JANX"
cik: "0001817713"
company_name: "Janux Therapeutics, Inc."
filed_at: "2021-07-16T23:59:59+00:00"
generated_at: "2026-06-30T04:53:41.690868+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Janux Therapeutics increases CEO base salary to $500k, bonus target to 50%

## Summary
- CEO David Campbell's annual base salary increased from $424,408 to $500,000 effective July 15, 2021.
- Annual target performance bonus percentage increased from 40% to 50%, retroactive to beginning of 2021.
- Changes approved by Board of Directors upon Compensation Committee recommendation.

## SEC filing metadata
- accession: 0001193125-21-217455
- form_type: 8-K
- ticker: JANX
- cik: 0001817713
- company_name: Janux Therapeutics, Inc.
- filed_at: 2021-07-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817713/000119312521217455/0001193125-21-217455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817713/000119312521217455/d139884d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-217455
- JSON: https://secwatch.observer/filing/0001193125-21-217455.json
- Plain text: https://secwatch.observer/filing/0001193125-21-217455.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.